Patents by Inventor Shoichi Kuroda
Shoichi Kuroda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230097871Abstract: The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof which has the effect of antagonizing the LPA1 receptor.Type: ApplicationFiled: July 29, 2020Publication date: March 30, 2023Applicant: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Shoichi KURODA, Yuki KOBAYASHI, Kanako HATANAKA, Yuji ITO, Fumito UNEUCHI, Yuko UEHARA
-
Patent number: 9932331Abstract: The present invention provides a compound represented by the following formula [1] or a pharmaceutically acceptable salt thereof which has an excellent NHE3 inhibitory effect: A-Y??[1] wherein A represents a structure represented by the following formula [2]: wherein R11 and R12 each represent a halogen atom or others as described herein, R2 represents C1-6 alkyl or others as described herein, ring E represents triazole, tetrazole, pyrimidine, or others as described herein, R31 and R32 each represent a hydrogen atom, C1-6 alkyl, C1-6 alkoxy, or others as described herein, and W represents a single bond, the formula —NH—, the formula —O—, or the formula —CONH—, and Y represents a hydrogen atom or a structure selected fromType: GrantFiled: July 24, 2015Date of Patent: April 3, 2018Assignee: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Shoichi Kuroda, Kenichi Kawabe, Yasunobu Ushiki, Hiroshi Ohta, Fumito Uneuchi, Tsuyoshi Shibata, Hideaki Tabuse, Eiji Munetomo, Sumi Chonan
-
Publication number: 20170210736Abstract: The present invention provides a compound represented by the following formula [1] or a pharmaceutically acceptable salt thereof which has an excellent NHE3 inhibitory effect: [Formula 15] A-Y??[1] wherein A represents a structure represented by the following formula [2]: wherein R11 and R12 each represent a halogen atom or the like, R2 represents C1-6 alkyl or the like, ring E represents triazole, tetrazole, pyrimidine, or the like, R31 and R32 each represent a hydrogen atom, C1-6 alkyl, C1-6 alkoxy, or the like, and W represents a single bond, the formula —NH—, the formula —O—, or the formula —CONH—, and Y represents a hydrogen atom or a structure represented by the following formula [3?]:Type: ApplicationFiled: July 24, 2015Publication date: July 27, 2017Applicant: TAISHO PHARMACEUTICAL CO., LTDInventors: Shoichi KURODA, Kenichi KAWABE, Yasunobu USHIKI, Hiroshi OHTA, Fumito UNEUCHI, Tsuyoshi SHIBATA, Hideaki TABUSE, Eiji MUNETOMO, Sumi CHONAN
-
Patent number: 9695148Abstract: This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior GK-activating effect and is useful as a pharmaceutical.Type: GrantFiled: November 12, 2013Date of Patent: July 4, 2017Assignee: Nissan Chemical Industries, Ltd.Inventors: Shoichi Kuroda, Yudai Imai, Takanori Kawaguchi, Keiko Fusegi, Masahiro Bohno, Hajime Asanuma, Tomomichi Chonan, Nagaaki Sato, Souichi Monma, Shigetada Sasako, Marie Mizutani, Shin Itoh, Takumi Okada, Hirofumi Ota, Seishi Ishiyama
-
Publication number: 20160289208Abstract: This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior UK-activating effect and is useful as a pharmaceutical.Type: ApplicationFiled: November 12, 2013Publication date: October 6, 2016Applicants: TAISHO PHARMACEUTICAL CO., LTD., NISSAN CHEMICAL INDUSTRIES, LTD.Inventors: Shoichi KURODA, Yudai IMAI, Takanori KAWAGUCHI, Keiko FUSEGI, Masahiro BOHNO, Hajime ASANUMA, Tomomichi CHONAN, Nagaaki SATO, Souichi MONMA, Shigetada SASAKO, Marie MIZUTANI, Shin ITOH, Takumi OKADA, Hirofumi OTA, Seishi ISHIYAMA
-
Patent number: 9181229Abstract: Provided are novel compounds that bind to FKBP12 or pharmaceutically acceptable salts thereof, as well as new therapeutics useful in the prevention or treatment of alopecia which comprise those compounds or pharmaceutically acceptable salts thereof. Specifically, compounds represented by formula (1) [where R1 represents either the following formula (2) or (3)] or pharmaceutically acceptable salts thereof are provided.Type: GrantFiled: March 15, 2012Date of Patent: November 10, 2015Assignee: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Naoya Ono, Shoichi Kuroda, Yoshihisa Shirasaki, Tetsuo Takayama, Yoshinori Sekiguchi, Fumihito Ushiyama, Yusuke Oka
-
Patent number: 8822503Abstract: A 2-pyridone compound represented by the formula [1]: {wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.Type: GrantFiled: April 6, 2011Date of Patent: September 2, 2014Assignees: Taisho Pharmaceutical Co., Ltd, Nissan Chemical Industries, Ltd.Inventors: Takanori Kawaguchi, Kengo Watatani, Keiko Fusegi, Masahiro Bohno, Hajime Asanuma, Shoichi Kuroda, Yudai Imai, Tomomichi Chonan, Nagaaki Sato, Shigeru Tokita, Shigetada Sasako, Takumi Okada, Keishi Hayashi, Shin Itoh, Noriko Saito, Rui Jibiki, Seishi Ishiyama, Hirofumi Ota
-
Patent number: 8637557Abstract: A compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which has a PI3 kinase ? inhibitory effect and is useful as a prophylactic or therapeutic agent for articular rheumatism, Crohn's disease, irritable colitis, Sjoegren's syndrome, multiple sclerosis, systemic lupus erythematosus, asthma, atopic dermatitis, arteriosclerosis, organ transplant rejection, cancer, retinopathy, psoriasis, arthrosis deformans, age-related macular degeneration, type II diabetes, insulin resistance, obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hyperlipemia, etc.Type: GrantFiled: October 4, 2010Date of Patent: January 28, 2014Assignee: Taisho Pharmaceutical Co., LtdInventors: Tetsuya Yabuuchi, Yusuke Oka, Shoichi Kuroda, Takahiro Oi, Yoshinori Sekiguchi
-
Publication number: 20130345419Abstract: Provided are novel compounds that bind to FKBP12 or pharmaceutically acceptable salts thereof, as well as new therapeutics useful in the prevention or treatment of alopecia which comprise those compounds or pharmaceutically acceptable salts thereof. Specifically, compounds represented by formula (1) [where R1 represents either the following formula (2) or (3)] or pharmaceutically acceptable salts thereof are provided.Type: ApplicationFiled: March 15, 2012Publication date: December 26, 2013Applicant: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Naoya Ono, Shoichi Kuroda, Yoshihisa Shirasaki, Tetsuo Takayama, Yoshinori Sekiguchi, Fumihito Ushiyama, Yusuke Oka
-
Patent number: 8461329Abstract: A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.Type: GrantFiled: December 25, 2009Date of Patent: June 11, 2013Assignee: Taisho Pharmaceutical Co., Ltd.Inventors: Tetsuo Takayama, Hajime Asanuma, Daisuke Wakasugi, Rie Nishikawa, Yoshinori Sekiguchi, Madoka Kawamura, Naoya Ono, Tetsuya Yabuuchi, Takahiro Oi, Yusuke Oka, Shoichi Kuroda, Fumito Uneuchi, Takeshi Koami
-
Publication number: 20120220767Abstract: A compound represented by formula (1) or a pharmaceutically acceptable salt thereof, which has a PI3 kinase ? inhibitory effect and is useful as a prophylactic or therapeutic agent for articular rheumatism, Crohn's disease, irritable colitis, Sjoegren's syndrome, multiple sclerosis, systemic lupus erythematosus, asthma, atopic dermatitis, arteriosclerosis, organ transplant rejection, cancer, retinopathy, psoriasis, arthrosis deformans, age-related macular degeneration, type II diabetes, insulin resistance, obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hyperlipemia, etc.Type: ApplicationFiled: October 4, 2010Publication date: August 30, 2012Applicant: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Tetsuya Yabuuchi, Yusuke Oka, Shoichi Kuroda, Takahiro Oi, Yoshinori Sekiguchi
-
Publication number: 20110288293Abstract: A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.Type: ApplicationFiled: December 25, 2009Publication date: November 24, 2011Applicant: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Tetsuo Takayama, Hajime Asanuma, Daisuke Wakasugi, Rie Nishikawa, Yoshinori Sekiguchi, Madoka Kawamura, Naoya Ono, Tetsuya Yabuuchi, Takahiro Oi, Yusuke Oka, Shoichi Kuroda, Fumito Uneuchi, Takeshi Koami
-
Publication number: 20110237791Abstract: A 2-pyridone compound represented by the formula [1]: {wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.Type: ApplicationFiled: April 6, 2011Publication date: September 29, 2011Applicants: TAISHO PHARMACEUTICAL CO., LTD, NISSAN CHEMICAL INDUSTRIES, LTD.Inventors: Takanori KAWAGUCHI, Kengo WATATANI, Keiko FUSEGI, Masahiro BOHNO, Hajime ASANUMA, Shoichi KURODA, Yudai IMAI, Tomomichi CHONAN, Nagaaki SATO, Shigeru TOKITA, Shigetada SASAKO, Takumi OKADA, Keishi HAYASHI, Shin ITOH, Noriko SAITO, Rui JIBIKI, Seishi ISHIYAMA, Hirofumi OTA
-
Patent number: 5770019Abstract: When waste liquid is concentrated using a radiant heat section and a heat absorbent section of a heat pump circuit, in the proper place of the heating region of the heat pump circuit, a detector for detecting the pressure and/or temperature of the heat transfer medium is provided, or a detector for detecting the value of an electric current flowing through or the amount of electric power consumed in a system which includes a compressor for the heat pump circuit, is provided, and by the provision of a control system which can halt the concentration operation when the detected value exceeds a set value, both with a liquid in which the concentration of the non-volatile component is low so that a comparatively long time is required for the concentration operation, and, conversely, with a liquid in which the concentration of the non-volatile component is high so that the concentration operation is completed in a comparatively short time, the concentration operation has good efficiency, and can always be halted atType: GrantFiled: December 13, 1994Date of Patent: June 23, 1998Assignees: Konica Corporation, The Tokyo Electric Power Company, Incorporated, Sanyo Electric Co., Ltd.Inventors: Masayuki Kurematsu, Satoshi Yuzawa, Shoichi Kuroda, Souichiro Shibata, Noriyuki Shimamura, Toshiaki Kawada, Yuio Yoshiokaya